WO1997010853A3 - Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope - Google Patents
Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope Download PDFInfo
- Publication number
- WO1997010853A3 WO1997010853A3 PCT/DE1996/001824 DE9601824W WO9710853A3 WO 1997010853 A3 WO1997010853 A3 WO 1997010853A3 DE 9601824 W DE9601824 W DE 9601824W WO 9710853 A3 WO9710853 A3 WO 9710853A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- type
- chelating agents
- radioactive isotopes
- nicotinamide
- functional
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU13005/97A AU1300597A (en) | 1995-09-21 | 1996-09-19 | N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes |
EP96944563A EP0851771A2 (de) | 1995-09-21 | 1996-09-19 | Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1995136783 DE19536783A1 (de) | 1995-09-21 | 1995-09-21 | Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope |
DE19536783.9 | 1995-09-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997010853A2 WO1997010853A2 (de) | 1997-03-27 |
WO1997010853A3 true WO1997010853A3 (de) | 1997-08-28 |
Family
ID=7773890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1996/001824 WO1997010853A2 (de) | 1995-09-21 | 1996-09-19 | Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0851771A2 (de) |
AU (1) | AU1300597A (de) |
CA (1) | CA2232340A1 (de) |
DE (1) | DE19536783A1 (de) |
WO (1) | WO1997010853A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19652374A1 (de) * | 1996-12-04 | 1998-06-10 | Schering Ag | Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung |
US7060251B1 (en) | 1997-09-08 | 2006-06-13 | The General Hospital Corporation | Imaging agents for early detection and monitoring of cardiovascular plaque |
AU9307498A (en) * | 1997-09-08 | 1999-03-29 | General Hospital Corporation, The | Imaging agents for early detection and monitoring of cardiovascular plaque |
US6388062B1 (en) | 1998-05-08 | 2002-05-14 | The Wistar Institute Of Anatomy And Biology | Modified p53 tetramerization domains having hydrophobic amino acid substitutions |
AU3875400A (en) * | 1999-03-12 | 2000-09-28 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | Hydrazide inhibitors of hiv-1 integrase |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
WO2003016302A1 (fr) | 2001-08-09 | 2003-02-27 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
WO2003000680A1 (fr) * | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
JP4630267B2 (ja) * | 2002-12-25 | 2011-02-09 | 第一三共株式会社 | ジアミン誘導体 |
CA2511493A1 (en) * | 2002-12-25 | 2004-07-15 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
CN1751025B (zh) * | 2002-12-25 | 2010-05-12 | 第一制药株式会社 | 二胺衍生物 |
JP2007510643A (ja) * | 2003-11-06 | 2007-04-26 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0403243A1 (de) * | 1989-06-16 | 1990-12-19 | Merck Frosst Canada Inc. | Chelat-Derivate von atrialnatriurethischem Faktor (ANF) |
WO1993015771A1 (en) * | 1992-02-06 | 1993-08-19 | Mallinckrodt Medical, Inc. | Ligands for improving metal chelate formation kinetics |
WO1994000489A2 (en) * | 1992-06-23 | 1994-01-06 | Diatech, Inc. | Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
WO1994009128A1 (en) * | 1992-10-22 | 1994-04-28 | Mallinckrodt Medical, Inc. | Therapeutic treatment for inhibiting vascular restenosis |
DE4301871A1 (de) * | 1993-01-13 | 1994-07-14 | Diagnostikforschung Inst | Neue Mittel zur Diagnose von Gefäßerkrankungen |
WO1995006633A1 (en) * | 1993-09-03 | 1995-03-09 | Resolution Pharmaceuticals Inc. | Hydrazino-type n2s2 chelators |
WO1995019791A1 (en) * | 1994-01-24 | 1995-07-27 | Neorx Corporation | Radiolabeled annexins |
WO1995032192A1 (en) * | 1994-05-19 | 1995-11-30 | Neorx Corporation | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
-
1995
- 1995-09-21 DE DE1995136783 patent/DE19536783A1/de not_active Withdrawn
-
1996
- 1996-09-19 EP EP96944563A patent/EP0851771A2/de not_active Withdrawn
- 1996-09-19 CA CA 2232340 patent/CA2232340A1/en not_active Abandoned
- 1996-09-19 AU AU13005/97A patent/AU1300597A/en not_active Abandoned
- 1996-09-19 WO PCT/DE1996/001824 patent/WO1997010853A2/de not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0403243A1 (de) * | 1989-06-16 | 1990-12-19 | Merck Frosst Canada Inc. | Chelat-Derivate von atrialnatriurethischem Faktor (ANF) |
WO1993015771A1 (en) * | 1992-02-06 | 1993-08-19 | Mallinckrodt Medical, Inc. | Ligands for improving metal chelate formation kinetics |
WO1994000489A2 (en) * | 1992-06-23 | 1994-01-06 | Diatech, Inc. | Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
WO1994009128A1 (en) * | 1992-10-22 | 1994-04-28 | Mallinckrodt Medical, Inc. | Therapeutic treatment for inhibiting vascular restenosis |
DE4301871A1 (de) * | 1993-01-13 | 1994-07-14 | Diagnostikforschung Inst | Neue Mittel zur Diagnose von Gefäßerkrankungen |
WO1995006633A1 (en) * | 1993-09-03 | 1995-03-09 | Resolution Pharmaceuticals Inc. | Hydrazino-type n2s2 chelators |
WO1995019791A1 (en) * | 1994-01-24 | 1995-07-27 | Neorx Corporation | Radiolabeled annexins |
WO1995032192A1 (en) * | 1994-05-19 | 1995-11-30 | Neorx Corporation | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
Non-Patent Citations (4)
Also Published As
Publication number | Publication date |
---|---|
EP0851771A2 (de) | 1998-07-08 |
WO1997010853A2 (de) | 1997-03-27 |
CA2232340A1 (en) | 1997-03-27 |
AU1300597A (en) | 1997-04-09 |
DE19536783A1 (de) | 1997-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0417870T3 (da) | Chelatdannere til kompleksbinding af radioaktive isotoper, metalkomplekser deraf samt anvendelsen deraf til diagnostik og terapi | |
WO1997010853A3 (de) | Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope | |
PL303843A1 (en) | Novel ligand compounds, method of obtaining them, complex compounds, method of diagnosing, pharmaceutical agent and diagnostic set | |
PL318043A1 (en) | Complex compounds of a cascade polymer, method of obtaining them and pharmaceutic agents containing such compounds | |
WO1997010852A3 (de) | Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsns für radioaktive isotope | |
GB2100121B (en) | Means for aligning and linking together articles such as furniture | |
EA199800998A3 (ru) | Хелатные соединения металлов с макроциклическими полиаминокарбоновыми соединениями и их использование для диагностических исследований | |
EP0662001A4 (de) | Multifunktionelle Liganden zur potentiellen Verwendung für das Design therapeutischer oder diagnostischer radiopharmazeutischer bildgebender Wirk-stoffe. | |
AU6501794A (en) | Chelating agents of the type xn1s1o1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy | |
WO1997012636A3 (de) | Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ s2ny für radioaktive isotope | |
TW253887B (de) | ||
WO1997012850A3 (de) | Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope | |
NO953868D0 (no) | Chelatdannere av typen XN1S1X' for radioaktive isotoper, deres metallkomplekser og deres anvendelse i diagnostikk og terapi | |
EP0588229A3 (en) | Macrocyclic chelating agents for the preparation of technetium or rhenium complexes | |
AU6501694A (en) | Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use | |
ZA851409B (en) | Bis(aminomethyl)bicyclo(2.2.1)heptanes useful as metal ion control agents and radioactive metals complexed therewith | |
DE69117741D1 (de) | Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen | |
KR960705842A (ko) | N-알킬 펩티드 킬레이트 형성제, 방사핵종을 갖는 그의 금속 착물, 이들의 제조방법 및 이들 화합물을 함유한 방사성의약 조성물(n-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compound) | |
NZ211192A (en) | Bis(aminomethyl)bicyclo(2.2.1)heptane derivatives as chelating agents, as metal ion precipitating inhibitors and as radioactive bone seeking complexes | |
HU9802311D0 (en) | Chelating agents for complex formation with radioactive isotopes, their metal complexes and the use thereof for diagnostic and therapeutic purposes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA HU JP KR NO NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA HU JP KR NO NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996944563 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2232340 Country of ref document: CA Ref country code: CA Ref document number: 2232340 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996944563 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996944563 Country of ref document: EP |